The names on today’s watchlist may look familiar, but the stories are moving. NeOnc Technologies Holdings (NASDAQ:NTHI) is approaching an important FDA discussion, XIAO-I Corporation (NASDAQ:AIXI) remains a high-volatility AI stock, and BIO-key International (NASDAQ:BKYI) is adding government customers in the Gulf. Meanwhile, Bolt Biotherapeutics (NASDAQ:BOLT) announced a major acquisition and financing package, Nautilus Biotechnology (NASDAQ:NAUT) is preparing to report earnings, and AI OKTO (NASDAQ:AIOK) declared a substantial special dividend. Across communications technology with ClearOne (NASDAQ:CLRO), staffing and recruiting with Robert Half (NYSE:RHI), and satellite cybersecurity with WISeSat.Space (NASDAQ: SAIQ).

There’s the move. NTHI cleared $3, pushed through the $3.30–$3.40 resistance area and touched $3.50. At the lunchtime snapshot, NeOnc Technologies Holdings (NASDAQ:NTHI) was trading around $3.45, up 17.12%, with approximately 168,800 shares changing hands.

With U.S. crude hovering just above $100 a barrel, 247 Market News is watching Kraig Biocraft Laboratories (OTCQB:KBLB), Hyperscale Data (NYSEAMERICAN:GPUS), Lucid Diagnostics (NASDAQ:LUCD), 22nd Century Group (NASDAQ:XXII), and Safe Harbor Financial (NASDAQ:SHFS).

Today’s watchlist may look familiar, as these names have been developing stories we have followed across previous reports, from a potential trading squeeze in XIAO-I (NASDAQ:AIXI) to NeOnc’s (NASDAQ:NTHI) brain-cancer programs. Others include BIO-key International (NASDAQ:BKYI), STAK (NASDAQ:STAK), WISeSat.Space (NASDAQ:SAIQ), and J-Star Holding (NASDAQ:YMAT).